In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Genocea Biosciences closes $23mm Series A round

Executive Summary

Vaccines company Genocea Biosciences raised $23mm in its Series A round led by first-time backer SR One. Other new investors Auriga Partners, Cycad Group, and Alexandria Real Estate Equities were joined by existing shareholders Lux Capital Management, Polaris Venture Partners, and Morningside Ventures.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register